C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
Open Access
- 2 July 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 617
Abstract
Objective: To explore the association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with risperidone-induced weight gain. Methods: We analyzed the association between MTHFR C677T polymorphism and risperidone-induced weight gain in 356 schizophrenia patients. The patients were treated with risperidone for 8 weeks. The height and body weight of the patients were measured before and 8 weeks after risperidone treatment. Blood DNA was genotyped for MTHFR C677T polymorphisms. Results: We found a significant association between MTHFR C677T polymorphism and body mass index (BMI) change after 8-week risperidone treatment. The BMI of carriers with different genotypes of MTHFR gene increased over 2–8 weeks. After 8 weeks of risperidone treatment, BMI added value (kg/m2) of CC or CT genotype carriers was significantly higher than that of TT genotype carriers [CC (4.47 ± 1.09), CT (4.54 ± 1.27), TT (2.31 ± 0.75), F = 5.634, P = 0.001]. Based on whether the rate of weight gain from baseline at 8 weeks of treatment exceeded 7%, it was divided into a weight gain group (n = 61) and a non-weight gain group (n = 295). The C allele frequency was significantly different between the two groups (48.4% vs 32.4%, χ2 = 11.342, P = 0.001). Conclusion: MTHFR C677T polymorphism was associated with risperidone-induced weight gain in Chinese Han population.Keywords
This publication has 29 references indexed in Scilit:
- Are MTHFR C677T and MTRR A66G Polymorphisms Associated with Overweight/Obesity Risk? From a Case-Control to a Meta-Analysis of 30,327 SubjectsInternational Journal of Molecular Sciences, 2015
- Leptin -2548g/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study.2014
- Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbancesJournal of Psychiatric Research, 2014
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?International Journal of Neuropsychopharmacology, 2013
- Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewClinical Psychopharmacology and Neuroscience, 2012
- Association of the MTHFR gene with Antipsychotic-induced Metabolic Abnormalities in Patients with SchizophreniaPharmacogenomics, 2012
- Pharmacogenetics and SchizophreniaClinics In Laboratory Medicine, 2010
- Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent mannerMetabolism, 2010
- Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?Journal of Endocrinological Investigation, 2007
- Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient populationClinica Chimica Acta, 2004